Sale!

MED25 Gene CMT2B2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MED25 Gene CMT2B2 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the MED25 gene, which are associated with Charcot-Marie-Tooth disease type 2B2 (CMT2B2). CMT2B2 is a subtype of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems, primarily in the feet and legs, but also in the hands and arms as the condition progresses. The test is crucial for individuals with a family history of CMT2B2 or those showing symptoms, as it provides definitive genetic evidence of the condition. This information is vital for planning appropriate management and treatment strategies. The test cost is set at 4400 AED and is conducted with precision and care by the experienced professionals at DNA Labs UAE, ensuring reliable results for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MED25 Gene CMT2B2 Genetic Test

Cost: AED 4400.0

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for MED25 Gene CMT2B2 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with MED25 Gene CMT2B2

Test Details

The MED25 gene is associated with CMT2B2, a subtype of Charcot-Marie-Tooth disease (CMT) that is characterized by progressive weakness and atrophy of the muscles in the feet and lower legs. CMT2B2 is caused by mutations in the MED25 gene, which provides instructions for making a protein that is involved in the regulation of gene expression.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once using advanced sequencing technology. NGS genetic testing can be used to identify mutations in the MED25 gene that are associated with CMT2B2.

NGS genetic testing for CMT2B2 may be recommended for individuals with symptoms of CMT, such as muscle weakness, atrophy, and sensory loss in the feet and lower legs. It may also be recommended for individuals with a family history of CMT or a known mutation in the MED25 gene.

The results of NGS genetic testing for CMT2B2 can help diagnose the condition and guide treatment and management decisions. There is currently no cure for CMT, but early diagnosis and management can help improve quality of life and slow the progression of the disease.

Test Name MED25 Gene CMT2B2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MED25 Gene CMT2B2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MED25 Gene CMT2B2
Test Details

The MED25 gene is associated with CMT2B2, a subtype of Charcot-Marie-Tooth disease (CMT) that is characterized by progressive weakness and atrophy of the muscles in the feet and lower legs. CMT2B2 is caused by mutations in the MED25 gene, which provides instructions for making a protein that is involved in the regulation of gene expression.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once using advanced sequencing technology. NGS genetic testing can be used to identify mutations in the MED25 gene that are associated with CMT2B2.

NGS genetic testing for CMT2B2 may be recommended for individuals with symptoms of CMT, such as muscle weakness, atrophy, and sensory loss in the feet and lower legs. It may also be recommended for individuals with a family history of CMT or a known mutation in the MED25 gene.

The results of NGS genetic testing for CMT2B2 can help diagnose the condition and guide treatment and management decisions. There is currently no cure for CMT, but early diagnosis and management can help improve quality of life and slow the progression of the disease.